Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TPM-203 by Topas Therapeutics for Pemphigus Vulgaris: Likelihood of Approval
TPM-203 is under clinical development by Topas Therapeutics and currently in Phase I for Pemphigus Vulgaris. According to GlobalData, Phase...